The emergence of the new pathogen SARS-CoV-2 determined a rapid need for monoclonal antibodies (mAbs) to detect the virus in biological fluids as a rapid tool to identify infected individuals to be treated or quarantined. The majority of commercially available antigenic tests for SARS-CoV-2 rely on the detection of N antigen in biologic fluid using anti-N antibodies. and their capacit... https://www.nacrack.com/mega-pick-As-for-Me-and-My-House-Wall-Decal-in-Hebrew-Yahauh-flash-find/